Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,572 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo.
Grant-Serroukh D, Hunter MR, Maeshima R, Tagalakis AD, Aldossary AM, Allahham N, Williams GR, Edbrooke M, Desai A, Hart SL. Grant-Serroukh D, et al. Among authors: desai a. J Control Release. 2022 Aug;348:786-797. doi: 10.1016/j.jconrel.2022.06.018. Epub 2022 Jun 26. J Control Release. 2022. PMID: 35718210 Free article.
Understanding Intracellular Biology to Improve mRNA Delivery by Lipid Nanoparticles.
Hunter MR, Cui L, Porebski BT, Pereira S, Sonzini S, Odunze U, Iyer P, Engkvist O, Lloyd RL, Peel S, Sabirsh A, Ross-Thriepland D, Jones AT, Desai AS. Hunter MR, et al. Among authors: desai as. Small Methods. 2023 Sep;7(9):e2201695. doi: 10.1002/smtd.202201695. Epub 2023 Jun 14. Small Methods. 2023. PMID: 37317010 Free PMC article.
Nanomedicines for the Delivery of Biologics.
Wahlich J, Desai A, Greco F, Hill K, Jones AT, Mrsny RJ, Pasut G, Perrie Y, Seib FP, Seymour LW, Uchegbu IF. Wahlich J, et al. Among authors: desai a. Pharmaceutics. 2019 May 3;11(5):210. doi: 10.3390/pharmaceutics11050210. Pharmaceutics. 2019. PMID: 31058802 Free PMC article.
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial.
Lassen MCH, Ostrominski JW, Inzucchi SE, Claggett BL, Kulac I, Jhund P, de Boer RA, Hernandez AF, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Desai AS, Petersson M, Langkilde AM, Docherty KF, McMurray JJV, Solomon SD, Vaduganathan M. Lassen MCH, et al. Among authors: desai as. Eur J Heart Fail. 2024 May 15. doi: 10.1002/ejhf.3269. Online ahead of print. Eur J Heart Fail. 2024. PMID: 38745498
3,572 results